Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 May-Jun;5(3):335-6.
doi: 10.4161/mabs.24106. Epub 2013 Mar 14.

Monoclonal antibodies targeting CD20

Chien-Hsing Chang  1 , Edmund A Rossi  1 , David M Goldenberg  1
Affiliations
Comment

Monoclonal antibodies targeting CD20

Chien-Hsing Chang et al. MAbs. 2013 May-Jun.
No abstract available

PubMed Disclaimer

Comment in

  • Response to: monoclonal antibodies targeting CD20.
    Klein C, Lammens A, Schäfer W, Georges G, Schwaiger M, Mössner E, Hopfner KP, Umaña P, Niederfellner G. Klein C, et al. MAbs. 2013 May-Jun;5(3):337-8. doi: 10.4161/mabs.24108. Epub 2013 Mar 14. MAbs. 2013. PMID: 23493087 Free PMC article. No abstract available.

Comment on

References

    1. Klein C, Lammens A, Schäfer W, Georges G, Schwaiger M, Mössner E, et al. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties. MAbs. 2013;5:22–33. doi: 10.4161/mabs.22771. - DOI - PMC - PubMed
    1. Keating GM. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma. Drugs. 2010;70:1445–76. doi: 10.2165/11201110-000000000-00000. - DOI - PubMed
    1. Maloney DG. Anti-CD20 antibody therapy for B-cell lymphomas. N Engl J Med. 2012;366:2008–16. doi: 10.1056/NEJMct1114348. - DOI - PubMed
    1. Fleischmann RM. Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on rituximab. Semin Arthritis Rheum. 2009;38:265–80. doi: 10.1016/j.semarthrit.2008.01.001. - DOI - PubMed
    1. Goldenberg DM, Rossi EA, Stein R, Cardillo TM, Czuczman MS, Hernandez-Ilizaliturri FJ, et al. Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody. Blood. 2009;113:1062–70. doi: 10.1182/blood-2008-07-168146. - DOI - PMC - PubMed

LinkOut - more resources